## Abstract Extranodal, nasal NK/T‐cell lymphomas are regularly Epstein‐Barr virus (EBV)‐positive, with a type II latency pattern, expressing thus EBNA‐1 and LMP1. The contribution of EBV to the tumor development is not known. Similarly to normal natural killer (NK) cells, cell lines derived from m
IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: Promotion of IL6 receptor expression by EBV
✍ Scribed by S. C. Klein; M. Jücker; H. Abts; Dr. H. Tesch
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 593 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
✦ Synopsis
We have analysed a panel of different Burkitt's lymphoma (BL) and lymphoblastoid cell lines (LCLs) for the expression of IL6 and IL6 receptor (IL6R). Epstein-Barr-Virus (EBV) positive or negative BL cell lines and the corresponding lymphoblastoid cell lines (LCL), derived from EBV immortalized mononuclear cells of the BL patients, were tested for the expression of IL6 mRNA and protein by Northern blot experiments and ELISA, and for the expression of the IL6R mRNA and protein by Northern blot Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and flow cytometry. Our results demonstrate that six out of 19 Burkitt's lymphoma cell lines produced IL6 constitutively. All three cell lines infected with the EBV substrain B95-8 (B95-8 convertants) produced IL6, in contrast to the original EBV negative lines and to the cell lines infected with the EBV substrain P3HRI (P3HRl convertants). The produced IL6 was biologically active as shown by proliferation of the IL6 dependent cell line TEPC 1033 C2. The two BL cell lines with the highest level of IL6 production (190pg/ml and 550pg/ml) expressed in addition IL6R molecules on the cell surface. Monoclonal antibodies directed against IL6 did not inhibit the growth of these two BL cell lines, thus excluding autocrine stimulation in these lines. IL6R expression could be further demonstrated in all LCLs analysed, in five out of seven EBV positive BLs and two out of three B95-8 convertants, but only in one out of the six EBV negative BL cell lines. Our results suggest that EBV in immortalized B cells and in Burkitt's lymphoma cells can promote IL6 receptor expression.
📜 SIMILAR VOLUMES
Increasing evidence supports an essential role for interleukin-6 (IL-6) in the development, differentiation, as well as de-and re-generation of neurons in the central nervous system (CNS). Both IL-6 and its specific receptor (IL-6R) are expressed on neurons and glial cells including astrocytes. In t
## Abstract Lytically infected EBV‐positive lymphoblastoid cells enhance the growth of early‐passage, but not late‐passage, EBV‐immortalized lymphoblastoid cell lines (LCLs) in SCID mice and have enhanced IL‐6 secretion. Here, we have examined the importance of IL‐6 for the growth of early‐passage
## Expression of glucocorticoid receptor spliced variants in lymphoma cell lines To the Editor Glucocorticoid (GC) has been commonly used as an anti-inflammatory reagent and a component of chemotherapeutic regimens for inducing apoptosis of haematological malignancies including leukaemia, multiple
## Abstract Human T‐cell leukemia virus type‐I (HTLV‐I) encodes for the viral protein Tax, which is known to significantly disrupt transcriptional control of cytokines, cytokine receptors and other immuno‐modulatory proteins in T cells. Specific dysregulation of these factors can alter the course a